Completed Digestion, Kidneys & Other Organs Infection & Immunity
A First-in-Human Phase I Clinical Trial for the Novel Clostridium difficile Antibiotic SMT19969.
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at Summit Corporation PLC.
View the original record at the funder ↗
Researchers
Vickers (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Phase IIa Clinical Trial for a Novel Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Preclinical development and assessment of an oral therapeutic for Clostridium difficile infection
Development of a type B lantibiotic for treatment of Clostridium difficile infection (CDI).
Development of a novel class of antibiotics for the targeted treatment of Clostridium Difficile infection.
Development of a high throughput comparative microbiomics platform applied to Clostdridium difficile-associated disease.
Original classification
Translation AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know